[go: up one dir, main page]

ZA200810862B - Alkyl-pyridazine derivatives as inhibitors of 11 beta hydroxysteroid dehydrogenase type 1(11B-HSD 1) - Google Patents

Alkyl-pyridazine derivatives as inhibitors of 11 beta hydroxysteroid dehydrogenase type 1(11B-HSD 1)

Info

Publication number
ZA200810862B
ZA200810862B ZA200810862A ZA200810862A ZA200810862B ZA 200810862 B ZA200810862 B ZA 200810862B ZA 200810862 A ZA200810862 A ZA 200810862A ZA 200810862 A ZA200810862 A ZA 200810862A ZA 200810862 B ZA200810862 B ZA 200810862B
Authority
ZA
South Africa
Prior art keywords
hsd
inhibitors
alkyl
hydroxysteroid dehydrogenase
dehydrogenase type
Prior art date
Application number
ZA200810862A
Other languages
English (en)
Inventor
Kurt Amrein
Daniel Hunziker
Bernd Kuhn
Alexander V Mayweg
Werner Neidhart
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ZA200810862B publication Critical patent/ZA200810862B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/08—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200810862A 2006-07-05 2008-12-23 Alkyl-pyridazine derivatives as inhibitors of 11 beta hydroxysteroid dehydrogenase type 1(11B-HSD 1) ZA200810862B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06116596 2006-07-05

Publications (1)

Publication Number Publication Date
ZA200810862B true ZA200810862B (en) 2009-12-30

Family

ID=38566130

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200810862A ZA200810862B (en) 2006-07-05 2008-12-23 Alkyl-pyridazine derivatives as inhibitors of 11 beta hydroxysteroid dehydrogenase type 1(11B-HSD 1)

Country Status (19)

Country Link
US (1) US7547697B2 (zh)
EP (1) EP2044034B1 (zh)
JP (1) JP4959794B2 (zh)
KR (1) KR101089012B1 (zh)
CN (1) CN101484428B (zh)
AR (1) AR061806A1 (zh)
AU (1) AU2007271273B2 (zh)
BR (1) BRPI0714200A2 (zh)
CA (1) CA2655692C (zh)
CL (1) CL2007001945A1 (zh)
ES (1) ES2391583T3 (zh)
IL (1) IL196120A (zh)
MX (1) MX2008016426A (zh)
NO (1) NO20090009L (zh)
PE (1) PE20080399A1 (zh)
RU (1) RU2417989C2 (zh)
TW (1) TWI329104B (zh)
WO (1) WO2008003611A1 (zh)
ZA (1) ZA200810862B (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2008001839A1 (es) 2007-06-21 2009-01-16 Incyte Holdings Corp Compuestos derivados de 2,7-diazaespirociclos, inhibidores de 11-beta hidroxil esteroide deshidrogenasa tipo 1; composicion farmaceutica que comprende a dichos compuestos; utiles para tratar la obesidad, diabetes, intolerancia a la glucosa, diabetes tipo ii, entre otras enfermedades.
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US8501940B2 (en) * 2008-07-15 2013-08-06 Hoffmann-La Roche Inc. Tetrahydrocinnoline derivatives
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
WO2011157827A1 (de) 2010-06-18 2011-12-22 Sanofi Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
CA2850584A1 (en) 2011-11-14 2013-05-23 F. Hoffmann-La Roche Ag 1-pyridazinyl-hydroxyimino-3-phenyl-propanes as gpbar1 agonists
EP3235813A1 (en) 2016-04-19 2017-10-25 Cidqo 2012, S.L. Aza-tetra-cyclo derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004011410A1 (en) * 2002-07-27 2004-02-05 Astrazeneca Ab Chemical compounds
TW200503994A (en) 2003-01-24 2005-02-01 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
CN101484428A (zh) 2009-07-15
AU2007271273B2 (en) 2011-09-01
PE20080399A1 (es) 2008-04-28
NO20090009L (no) 2009-01-08
JP2009541434A (ja) 2009-11-26
RU2417989C2 (ru) 2011-05-10
ES2391583T3 (es) 2012-11-28
TWI329104B (en) 2010-08-21
EP2044034A1 (en) 2009-04-08
IL196120A0 (en) 2009-09-01
KR101089012B1 (ko) 2011-12-01
TW200811115A (en) 2008-03-01
JP4959794B2 (ja) 2012-06-27
US7547697B2 (en) 2009-06-16
EP2044034B1 (en) 2012-08-22
AR061806A1 (es) 2008-09-24
CA2655692A1 (en) 2008-01-10
BRPI0714200A2 (pt) 2012-12-25
CL2007001945A1 (es) 2008-02-08
US20080009499A1 (en) 2008-01-10
RU2009103650A (ru) 2010-08-10
AU2007271273A1 (en) 2008-01-10
IL196120A (en) 2013-02-28
CN101484428B (zh) 2011-11-16
MX2008016426A (es) 2009-01-19
WO2008003611A1 (en) 2008-01-10
CA2655692C (en) 2012-01-03
KR20090026214A (ko) 2009-03-11

Similar Documents

Publication Publication Date Title
ZA200810862B (en) Alkyl-pyridazine derivatives as inhibitors of 11 beta hydroxysteroid dehydrogenase type 1(11B-HSD 1)
TWI347321B (en) Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
HRP20150197T1 (en) Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1
TWI365067B (en) N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
HK1112463A1 (en) Imidazo- and triazolopyridines as inhibitors of 11-beta hydroxysteroid dehydrogenase type i
TWI365871B (en) Tricyclic adamantylamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
IL192580A0 (en) Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors
IL196989A0 (en) Cyclic ii-?? hydroxysteroid dehydrogenase type 1 inhibitors
TWI372623B (en) Inhibitors of 11β-hydroxysteroid dehydrogenase
IL222698A0 (en) Benzazole derivatives, compositions, and methods of use as b- secretase inhibitors
PL2173173T3 (pl) Podstawione pochodne 6-anilinopuryny jako inhibitory oksydazy/dehydrogenazy cytokinin i preparaty zawierające te pochodne
IL208896A0 (en) Synthesis of inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
ZA200903286B (en) Hydantoin derivatives used as MMP Inhibitors
HK1224181A1 (zh) 抑制 氧化酶活性的組合物
IL196000A0 (en) 2-arylindole derivatives as npges-i inhibitors
SI2035379T1 (sl) Inhibitorji 11-beta-hidroksisteroid dehidrogeneaze 1
ZA200710220B (en) Imidazo- and traizolopyridines as inhibitors as 11-beta hydroxysteroid dehydrogenase type I